TTrialPathMatch Me to Trials
← Back to trials
RecruitingKnee Osteoarthritis

SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty

Eligible age

65–100 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This randomized controlled trial evaluates the effect of ultrasound-guided iPACK block with Adductor Canal Block (ACB) on the Systemic Immune-Inflammation Index (SII) in elderly patients undergoing total hip arthroplasty under spinal anesthesia. SII, calculated as platelet × neutrophil / lymphocyte count, is used as a composite marker of perioperative inflammatory and immune response. The study investigates whether iPACK block with ACB attenuates the systemic inflammatory reaction to surgical trauma compared to sham block.

Sponsor: Poznan University of Medical Sciences

You may qualify if…

  • ✓ Patients with ASA classification I-III
  • ✓ Aged 65-100 years
  • ✓ Who will be scheduled for hip arthroplasty under spinal anesthesia

You may not qualify if…

  • ✕ Patients who have a history of bleeding diathesis
  • ✕ Take anticoagulant therapy
  • ✕ History of chronic pain before surgery
  • ✕ Multiple trauma
  • ✕ patients unable to assess their pain (dementia)
  • ✕ patients operated under general anesthesia
  • ✕ patients having an infection in the region of the procedure
  • ✕ the patient who does not accept the procedure

Source: ClinicalTrials.gov · NCT07449442 · last updated 2026-05-22

SII Levels Following iPACK Block With Adductor Canal Block in Knee Art · TrialPath